Streetbeat News

Revenues

JBI

In the past three months, analysts have shown a mixed outlook on Janus Intl Gr (NYSE:JBI), with recent ratings indicating a downward trend in price targets. The average 12-month price target is now $13.25, down from $16.88. Analysts have lowered their ratings and price targets due to market conditions and company performance. Despite challenges like a decline in revenue growth, Janus Intl Gr maintains strong profitability with a high net margin and ROE.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

CVS

Analysts have mixed views on CVS Health, with recent ratings showing a majority as indifferent. The average 12-month price target is $62.33, slightly down from previous estimates. CVS Health's financial metrics indicate challenges in profitability and asset utilization, despite strong market capitalization and revenue growth.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

INSM

Insmed (NASDAQ:INSM) has significantly outperformed the market over the past decade, with an annualized return of 18.36%. A $1000 investment in Insmed 10 years ago would now be worth $5,347.05, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

PODD

Insulet (NASDAQ:PODD) has significantly outperformed the market over the past 15 years, with an average annual return of 22.2%. A $1000 investment in Insulet 15 years ago would now be worth $20,354.17. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 4:00 pm

UA

UAA

Under Armour shares declined following a restructuring update and a reduced FY25 outlook.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:49 pm

BKNG

Booking Holdings (NASDAQ:BKNG) has significantly outperformed the market over the past 15 years, with an average annual return of 23.15%. A $1000 investment in BKNG 15 years ago would now be worth $23,436.42, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 3:30 pm

CI

Cigna (NYSE:CI) has outperformed the market over the past 10 years with an average annual return of 14.39%, surpassing the market by 3.83% annually. A $100 investment in Cigna 10 years ago would now be worth $390.66.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 3:30 pm

BA

Boeing has delivered 258 airplanes year-to-date through August 31, including 198 Max models. The company reported 207 net orders and 250 gross orders for the same period. In August, Boeing delivered 40 commercial jets, an increase of 5 from the previous year, including 32 737 Max models.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:03 pm

MBUU

Analysts have mixed ratings for Malibu Boats (NASDAQ:MBUU), with recent price targets averaging $39.25, down from $42.00. The company faces a significant revenue decline but maintains strong net margins and ROE. Analysts' actions reflect varied expectations for Malibu's future performance.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 3:01 pm

LAD

Lithia Motors (NYSE:LAD) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $332.5, indicating positive expectations. Analysts have raised their ratings and price targets, reflecting confidence in Lithia's market performance and growth potential.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 3:01 pm